Sapiens Reports Third Quarter 2019 Financial Results
HOLON,

|
Summary Results for Third Quarter 2019 (USD in millions, except per share data) |
||||||
|
GAAP |
% Change |
Non-GAAP |
% Change |
|||
|
Q3-2019 |
Q3-2018 |
Q3-2019 |
Q3-2018 |
|||
|
Revenue |
|
|
12.8% |
|
|
12.8% |
|
Gross Profit |
|
|
19.9% |
|
|
18.8% |
|
Gross Margin |
40.3% |
38.0% |
230 bps |
44.4% |
42.2% |
220 bps |
|
Operating Income |
|
|
48.4% |
|
|
31.7% |
|
Operating Margin |
12.2% |
9.3% |
290 bps |
16.4% |
14.0% |
240 bps |
|
Net income (*) |
|
|
43.1% |
|
|
37.9% |
|
Diluted EPS |
|
|
50% |
|
|
40% |
|
(*) Attributable to Sapiens' shareholders |
||||||
"The third quarter demonstrated continued execution of Sapiens' 2019 priorities: top-line growth and margin expansion. Non-GAAP revenue increased 12.8%, primarily due to continued expansion in our property & casualty (P&C) divisions, and initial growth in our life & annuity (L&A) division," said
"A global focus on Sapiens' key objectives to leverage our offshore capabilities, along with improved economies of scale, drove a non-GAAP operating margin improvement of 240 basis points. The increase in operating income has fueled continued expansion of Sapiens' product, sales and delivery teams, all of which are key to building next year's pipeline and supporting our capacity to deliver current projects. Sapiens is confident we have built a platform that can support long term top-line growth, with the infrastructure to cost-effectively support our long-term profitability."
Continued Al-Dor: "I'm encouraged by our pipeline of business and anticipated growth for the remainder of 2019. Following the acquisition of Calculo, we are increasing our full-year, non-GAAP revenue to a range of
Quarterly Results Conference Call
Management will host a conference call and webcast on
The live webcast of the call can be viewed on Sapiens' website at: https://www.sapiens.com/investor-relations/ir-events-presentations/
If you are unable to join live, a replay of the call will be accessible until
A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.
Non-GAAP Financial Measures
This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.
Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.
Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, restructuring and cost reduction costs, tax adjustments related to non-GAAP adjustments, and acquisition-related costs, which pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.
Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.
To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.
Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.
The Company defines Adjusted EBITDA as net profit, adjusted for valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.
The Company uses Adjusted EBITDA as a measurement of its operating performance, and reconciles Non-GAAP Operating Income to Adjusted EBITDA, adjusted for amortization and capitalization of capitalized software and amortization other intangible assets, stock-based compensation and acquisition-related costs, and valuation adjustment on acquired deferred revenues. The Company uses Adjusted EBITDA, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.
The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow while reducing the amounts for capitalization of software development costs and capital expenditures, and adds back payments related to investment in new campus in
About Sapiens
Forward Looking Statement
Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.
These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended
|
|
|||||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
|||||||||
|
|
|||||||||
|
Three months ended |
Nine months ended |
||||||||
|
|
September 30 |
||||||||
|
2019 |
2018 |
2019 |
2018 |
||||||
|
(unaudited) |
(unaudited) |
(unaudited) |
(unaudited) |
||||||
|
Revenue |
82,643 |
73,237 |
238,959 |
216,396 |
|||||
|
Cost of revenue |
49,316 |
45,438 |
144,371 |
134,710 |
|||||
|
Gross profit |
33,327 |
27,799 |
94,588 |
81,686 |
|||||
|
Operating expenses: |
|||||||||
|
Research and development, net |
9,445 |
8,350 |
27,145 |
26,130 |
|||||
|
Selling, marketing, general and administrative |
13,767 |
12,635 |
39,797 |
39,117 |
|||||
|
Total operating expenses |
23,212 |
20,985 |
66,942 |
65,247 |
|||||
|
Operating income |
10,115 |
6,814 |
27,646 |
16,439 |
|||||
|
Financial expense, net |
261 |
974 |
1,749 |
3,128 |
|||||
|
Taxes and other expenses, net |
2,349 |
629 |
6,350 |
3,143 |
|||||
|
Net income |
7,505 |
5,211 |
19,547 |
10,168 |
|||||
|
Attributable to non-controlling interest |
87 |
28 |
134 |
135 |
|||||
|
Net income attributable to Sapiens' shareholders |
7,418 |
5,183 |
19,413 |
10,033 |
|||||
|
Basic earnings per share |
0.15 |
0.10 |
0.39 |
0.20 |
|||||
|
Diluted earnings per share |
0.15 |
0.10 |
0.38 |
0.20 |
|||||
|
Weighted average number of shares outstanding used to |
50,027 |
49,826 |
50,005 |
49,795 |
|||||
|
Weighted average number of shares outstanding used to |
50,742 |
50,143 |
50,534 |
50,070 |
|||||
|
|
|||||||||
|
CONDENSED CONSOLIDATED NON-GAAP STATEMENTS OF INCOME |
|||||||||
|
|
|||||||||
|
Three months ended |
Nine months ended |
||||||||
|
|
September 30 |
||||||||
|
2019 |
2018 |
2019 |
2018 |
||||||
|
(unaudited) |
(unaudited) |
(unaudited) |
(unaudited) |
||||||
|
Revenue |
82,643 |
73,237 |
238,959 |
216,864 |
|||||
|
Cost of revenue |
45,931 |
42,334 |
134,349 |
125,240 |
|||||
|
Gross profit |
36,712 |
30,903 |
104,610 |
91,624 |
|||||
|
Operating expenses: |
|||||||||
|
Research and development, net |
10,986 |
9,658 |
31,648 |
29,908 |
|||||
|
Selling, marketing, general and administrative |
12,196 |
10,972 |
35,101 |
33,005 |
|||||
|
Total operating expenses |
23,182 |
20,630 |
66,749 |
62,913 |
|||||
|
Operating income |
13,530 |
10,273 |
37,861 |
28,711 |
|||||
|
Financial expense, net |
261 |
974 |
1,749 |
3,128 |
|||||
|
Taxes and other expenses |
2,770 |
1,723 |
7,635 |
5,211 |
|||||
|
Net income |
10,499 |
7,576 |
28,477 |
20,372 |
|||||
|
Attributable to non-controlling interest |
87 |
28 |
134 |
135 |
|||||
|
Net income attributable to Sapiens' shareholders |
10,412 |
7,548 |
28,343 |
20,237 |
|||||
|
Basic earnings per share |
0.21 |
0.15 |
0.57 |
0.41 |
|||||
|
Diluted earnings per share |
0.21 |
0.15 |
0.56 |
0.40 |
|||||
|
Weighted average number of shares outstanding used to |
50,027 |
49,826 |
50,005 |
49,795 |
|||||
|
Weighted average number of shares outstanding used to |
50,742 |
50,143 |
50,534 |
50,070 |
|||||
|
|
|||||||||
|
RECONCILIATION OF GAAP TO NON-GAAP RESULTS |
|||||||||
|
|
|||||||||
|
Three months ended |
Nine months ended |
||||||||
|
|
September 30 |
||||||||
|
2019 |
2018 |
2019 |
2018 |
||||||
|
(unaudited) |
(unaudited) |
(unaudited) |
(unaudited) |
||||||
|
GAAP revenue |
82,643 |
73,237 |
238,959 |
216,396 |
|||||
|
Valuation adjustment on acquired deferred revenue |
- |
- |
- |
468 |
|||||
|
Non-GAAP revenue |
82,643 |
73,237 |
238,959 |
216,864 |
|||||
|
GAAP gross profit |
33,327 |
27,799 |
94,588 |
81,686 |
|||||
|
Valuation adjustment on acquired deferred revenue |
- |
- |
- |
468 |
|||||
|
Amortization of capitalized software |
1,438 |
1,205 |
4,169 |
3,612 |
|||||
|
Amortization of other intangible assets |
1,947 |
1,899 |
5,853 |
5,858 |
|||||
|
Non-GAAP gross profit |
36,712 |
30,903 |
104,610 |
91,624 |
|||||
|
GAAP operating income |
10,115 |
6,814 |
27,646 |
16,439 |
|||||
|
Gross profit adjustments |
3,385 |
3,104 |
10,022 |
9,938 |
|||||
|
Capitalization of software development |
(1,541) |
(1,308) |
(4,503) |
(3,778) |
|||||
|
Amortization of other intangible assets |
539 |
739 |
1,614 |
2,367 |
|||||
|
Stock-based compensation |
382 |
384 |
1,123 |
1,470 |
|||||
|
Acquisition-related costs *) |
650 |
540 |
1,959 |
2,275 |
|||||
|
Non-GAAP operating income |
13,530 |
10,273 |
37,861 |
28,711 |
|||||
|
GAAP net income attributable to Sapiens' shareholders |
7,418 |
5,183 |
19,413 |
10,033 |
|||||
|
Operating income adjustments |
3,415 |
3,459 |
10,215 |
12,272 |
|||||
|
Tax and other |
(421) |
(1,094) |
(1,285) |
(2,068) |
|||||
|
Non-GAAP net income attributable to Sapiens' shareholders |
10,412 |
7,548 |
28,343 |
20,237 |
|||||
|
(*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date. |
|||||||||
|
Summary of NON-GAAP Financial Information |
|||||||||
|
|
|||||||||
|
Q3 2019 |
Q2 2019 |
Q1 2019 |
Q4 2018 |
Q3 2018 |
|||||
|
Revenues |
82,643 |
79,529 |
76,787 |
73,433 |
73,237 |
||||
|
Gross profit |
36,712 |
34,794 |
33,104 |
31,320 |
30,903 |
||||
|
Operating income |
13,530 |
12,581 |
11,750 |
10,849 |
10,273 |
||||
|
Net income to Sapiens' shareholders |
10,412 |
9,541 |
8,390 |
7,826 |
7,548 |
||||
|
Adjusted EBITDA |
14,523 |
13,358 |
12,524 |
11,797 |
11,236 |
||||
|
Basic earnings per share |
0.21 |
0.19 |
0.17 |
0.16 |
0.15 |
||||
|
Diluted earnings per share |
0.21 |
0.19 |
0.17 |
0.16 |
0.15 |
||||
|
Non-GAAP Revenues by Geographic Breakdown |
|||||||||
|
|
|||||||||
|
Q3 2019 |
Q2 2019 |
Q1 2019 |
Q4 2018 |
Q3 2018 |
|||||
|
|
44,413 |
39,216 |
38,149 |
34,974 |
36,734 |
||||
|
|
30,273 |
33,881 |
32,193 |
30,850 |
30,611 |
||||
|
|
4,087 |
3,515 |
3,670 |
3,140 |
3,480 |
||||
|
|
3,870 |
2,917 |
2,775 |
4,469 |
2,412 |
||||
|
Total |
82,643 |
79,529 |
76,787 |
73,433 |
73,237 |
||||
|
Adjusted Free Cash-Flow |
|||||||||
|
|
|||||||||
|
Q3 2019 |
Q2 2019 |
Q1 2019 |
Q4 2018 |
Q3 2018 |
|||||
|
Cash-flow from operating activities |
18,671 |
15,507 |
10,550 |
11,509 |
6,370 |
||||
|
Increase in capitalized software development costs |
(1,541) |
(1,570) |
(1,392) |
(1,382) |
(1,308) |
||||
|
Capital expenditures |
(973) |
(1,079) |
(641) |
(204) |
(831) |
||||
|
Capital expenditures related to new campus in |
(6,325) |
- |
- |
- |
- |
||||
|
Free cash-flow |
9,832 |
12,858 |
8,517 |
9,923 |
4,231 |
||||
|
Capital expenditures related to new campus in |
6,325 |
- |
- |
- |
- |
||||
|
Cash payments attributed to acquisition-related costs(*) (**) |
100 |
1,692 |
1,608 |
790 |
- |
||||
|
Adjusted free cash-flow |
16,257 |
14,550 |
10,125 |
10,713 |
4,231 |
||||
|
(*) Included in cash-flow from operating activities |
|||||||||
|
(**) Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date. |
|||||||||
|
Adjusted EBITDA Calculation |
||||||||
|
|
||||||||
|
Three months ended |
Nine months ended |
|||||||
|
|
September 30 |
|||||||
|
2019 |
2018 |
2019 |
2018 |
|||||
|
GAAP operating profit |
10,115 |
6,814 |
27,646 |
16,439 |
||||
|
Non-GAAP adjustments: |
||||||||
|
Amortization of capitalized software |
1,438 |
1,205 |
4,169 |
3,612 |
||||
|
Amortization of other intangible assets |
2,486 |
2,638 |
7,467 |
8,225 |
||||
|
Capitalization of software development |
(1,541) |
(1,308) |
(4,503) |
(3,778) |
||||
|
Stock-based compensation |
382 |
384 |
1,123 |
1,470 |
||||
|
Acquisition-related costs |
650 |
540 |
1,959 |
2,275 |
||||
|
Valuation adjustment on acquired deferred revenue |
- |
- |
- |
468 |
||||
|
Non-GAAP operating profit |
13,530 |
10,273 |
37,861 |
28,711 |
||||
|
Depreciation |
993 |
963 |
2,544 |
2,855 |
||||
|
Adjusted EBITDA |
14,523 |
11,236 |
40,405 |
31,566 |
||||
|
|
|||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||
|
|
|||||
|
|
|
||||
|
2019 |
2018 |
||||
|
(unaudited) |
(unaudited) |
||||
|
ASSETS |
|||||
|
CURRENT ASSETS |
|||||
|
Cash and cash equivalents |
73,138 |
64,628 |
|||
|
Trade receivables, net and unbilled receivables |
57,237 |
59,159 |
|||
|
Other receivables and prepaid expenses |
7,567 |
6,224 |
|||
|
Total current assets |
137,942 |
130,011 |
|||
|
LONG-TERM ASSETS |
|||||
|
Property and equipment, net |
15,446 |
8,515 |
|||
|
Severance pay fund |
5,052 |
4,699 |
|||
|
|
230,935 |
231,348 |
|||
|
Operating lease right-of-use assets |
52,747 |
- |
|||
|
Other long-term assets |
5,445 |
4,292 |
|||
|
Total long-term assets |
309,625 |
248,854 |
|||
|
TOTAL ASSETS |
447,567 |
378,865 |
|||
|
LIABILITIES AND EQUITY |
|||||
|
CURRENT LIABILITIES |
|||||
|
Trade payables |
5,506 |
6,149 |
|||
|
Current maturities of Series B Debentures |
9,898 |
9,898 |
|||
|
Accrued expenses and other liabilities |
54,848 |
46,999 |
|||
|
Current maturities of operating lease liabilities |
8,155 |
- |
|||
|
Deferred revenue |
22,691 |
18,057 |
|||
|
Total current liabilities |
101,098 |
81,103 |
|||
|
LONG-TERM LIABILITIES |
|||||
|
Series B Debentures, net of current maturities |
58,803 |
68,577 |
|||
|
Deferred tax liabilities |
9,040 |
11,681 |
|||
|
Other long-term liabilities |
8,228 |
9,398 |
|||
|
Long-term operating lease liabilities |
47,663 |
- |
|||
|
Accrued severance pay |
6,082 |
5,622 |
|||
|
Total long-term liabilities |
129,816 |
95,278 |
|||
|
EQUITY |
216,653 |
202,484 |
|||
|
TOTAL LIABILITIES AND EQUITY |
447,567 |
378,865 |
|||
|
|
||
|
CONSOLIDATED STATEMENT OF CASH FLOW |
||
|
|
||
|
For the nine months ended |
||
|
2019 |
2018 |
|
|
(unaudited) |
(unaudited) |
|
|
Cash flows from operating activities: |
||
|
Net income |
19,547 |
10,168 |
|
Reconciliation of net income (loss) to net cash provided by operating activities: |
||
|
Depreciation and amortization |
14,180 |
14,694 |
|
Accretion of discount on Series B Debentures |
124 |
140 |
|
Capital gain from sale of property and equipment |
(129) |
- |
|
Stock-based compensation related to options issued to employees |
1,123 |
1,462 |
|
Net changes in operating assets and liabilities, net of amount acquired: |
||
|
Trade receivables, net and unbilled receivables |
3,642 |
(10,654) |
|
Deferred tax assets |
(2,664) |
(2,448) |
|
Other operating assets |
1,425 |
(1,233) |
|
Trade payables |
(1,534) |
1,657 |
|
Other operating liabilities |
4,562 |
416 |
|
Deferred revenues |
4,419 |
1,937 |
|
Severance pay |
33 |
52 |
|
Net cash provided by operating activities |
44,728 |
16,191 |
|
Cash flows from investing activities: |
||
|
Purchase of property and equipment |
(9,018) |
(1,710) |
|
Investment in deposit |
(1,119) |
- |
|
Payments for business acquisition, net of cash acquired |
(1,572) |
(18,203) |
|
Proceeds from sale of property and equipment |
821 |
- |
|
Capitalized software development costs |
(4,503) |
(3,778) |
|
Net cash used in investing activities |
(15,391) |
(23,691) |
|
Cash flows from financing activities: |
||
|
Proceeds from employee stock options exercised |
435 |
532 |
|
Distribution of dividend |
(10,362) |
- |
|
Repayment of Series B Debentures |
(9,898) |
- |
|
Repayment of loan |
(4) |
(41) |
|
Payment of contingent considerations |
(120) |
(61) |
|
Dividend to non-controlling interest |
(66) |
(47) |
|
Net cash provided by financing activities |
(20,015) |
383 |
|
Effect of exchange rate changes on cash and cash equivalents |
(812) |
(271) |
|
Increase (decrease) in cash and cash equivalents |
8,510 |
(7,388) |
|
Cash and cash equivalents at the beginning of period |
64,628 |
71,467 |
|
Cash and cash equivalents at the end of period |
73,138 |
64,079 |
Debentures Covenants
As of
Covenant 1
- Target shareholders' equity (excluding minority interest): above
$120 million . - Actual shareholders' equity equal to
$215 million .
Covenant 2
- Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) bellow 65%.
- Actual ratio of net financial indebtedness to net capitalization equal to -1.81%.
Covenant 3
- Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
- Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to -0.07.
Investors and Media Contact
Chief Marketing Officer and Head of Corporate Communications
Mobile: +972 54-9099039
Email: [email protected]
View original content:http://www.prnewswire.com/news-releases/sapiens-reports-third-quarter-2019-financial-results-300950592.html
SOURCE


Hexaware to Present at Guidewire Connections 2019
3D Medical Imaging Devices Market to Witness Steady Growth Based on High Demand of Enriched Visual Pictures for Diagnosis, Till 2026 | Million Insights
Advisor News
- How advisors can prepare clients for an uncertain retirement landscape
- Investors aren’t waiting out uncertainty
- Transamerica and Advo(k)ate Advisors launch pooled employer plan
- ‘I wish I’d met him sooner:’ Karlan Tucker remembered for integrity, faith
- Why women must be more engaged in investing
More Advisor NewsAnnuity News
- AM Best Revises Outlooks to Negative for Subsidiaries of Group 1001 Insurance Holdings, LLC
- Market-value adjusted annuities: Key considerations for advisors
- Private equity’s next play in insurance
- Immediate Care Plan: A new solution for funding LTC
- Delaware Life Launches a New Bonus Fixed Index Annuity Built for Growth, Protection, and Flexibility
More Annuity NewsHealth/Employee Benefits News
- Studies from Harvard University T.H. Chan School of Public Health Describe New Findings in Managed Care [Preconception, prenatal and postnatal exposure to gaseous air pollutants (NO2, O3) and neurodevelopmental disorders in children among …]: Managed Care
- Studies from Harvard T.H. Chan School of Public Health Further Understanding of Managed Care (Structural Racism-related State Laws and Healthcare Access Among Black, Latine, and White Us Adults): Managed Care
- Data on Managed Care Reported by Researchers at University of California Berkeley (Welfare Program Participation Among Us Farmworkers Evidence From Three National Surveys): Managed Care
- ON MEDICAID'S 61ST ANNIVERSARY, A REMINDER PENNSYLVANIA REPUBLICANS CONTINUE TO PUSH DEVASTATING HEALTHCARE CUTS
- ON 61ST ANNIVERSARY OF MEDICAID, 10,000 FEWER ALASKANS HAVE COVERAGE AFTER PASSAGE OF DAN SULLIVAN'S AGENDA
More Health/Employee Benefits NewsLife Insurance News
- AM Best Revises Outlooks to Negative for Subsidiaries of Group 1001 Insurance Holdings, LLC
- Court sides with Ameritas in denying $4M STOLI payout to Wells Fargo
- AM Best Removes From Under Review With Positive Implications and Upgrades Credit Ratings of The Fortegra Group, Inc.’s Insurance Subsidiaries
- Yancey Jr., Delos Harley
- Vincent Esparza CFP, CLU joins Wilde Wealth Management Group as Senior Wealth Advisor
More Life Insurance News